Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Business Wire
Conducted in the United States and France, the OP5-003 Trial is the first Omnipod 5 study to include international participants.The OP5-003 Trial Presentation and Insulet Symposium will convey the importance of automated insulin delivery (AID) technology as Standard of Care.An expanded set of Omnipod 5 Real-World Evidence with more than 100,000 users will also be presented, showing positive outcomes and insights to guide system use and optimization. ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will present new clinical evidence related to the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) taking place March 6 – 9, 2024 in Florence, Italy, and online.“We are thrilled to unveil the results of our inaugural randomized controlled trial with groundb
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet (PODD) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now [Yahoo! Finance]Yahoo! Finance
- Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 2/22/24 - Beat
PODD
Sec Filings
- 4/25/24 - Form 3
- 4/9/24 - Form DEFA14A
- 4/9/24 - Form DEF
- PODD's page on the SEC website